🔎 Trials Near Me

Akèy › Amiloidoz › Ohio

Etid klinik pou Amiloidoz nan Ohio

6 etid pou Amiloidoz ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Cleveland
  • Clinical Trial Site, Columbus
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  • Clinical Trial Site, Columbus
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 8, 2026 · NCT04561518

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

  • Cleveland Clinic, Cleveland
Ap rekriteEtid obsèvasyon
Laj 30 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT05489549

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Cleveland Clinic, Cleveland
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

  • Research Site, Cleveland
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07081646

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • Cleveland Clinic, Cleveland
  • Ohio Health Research Institute, Columbus
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.